RA

Ritesh Aggarwal

Director Director DIN 01748549
DIN 01748549 First appointment Oct 2004 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2004
Shareholding value Locked Premium profile

About Ritesh Aggarwal

Data last updated:

Ritesh Aggarwal has 22 years in corporate governance. Formerly with 1 company, such as Justin Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01748549
Primary Designation Director
First Appointment 03 Oct 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director03 Oct 20041991Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Justin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ritesh Aggarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritesh Aggarwal

Ritesh Aggarwal has 22 years in corporate governance. Formerly with 1 company, such as Justin Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ritesh Aggarwal is associated with 0 companies as a director.

Ritesh Aggarwal has expertise in General Business.

Ritesh Aggarwal has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available